BioCentury and BIA’s 2nd CEO & Investor Dialogue: Biotech's Next Challenge

BioCentury and BIA’s 2nd CEO and Investor Dialogue - Biotech's Next Challenge: Delivering on the Story

If you survived the toughest downturn in biotech history: Congratulations on a job well done. But as we turn to 2025, the job will only get tougher for CEOs and Boards. You don’t have the luxury of time. You must deliver again, even in uncertain markets.

• ⁠How do you ensure discipline and advance your pipeline to the next inflection point?
• ⁠How do you experiment with AI and data science to accelerate drug development?
• How do you differentiate yourself from your peers to find the right investors, partners, and talent?

Join BioCentury, BIA, and special guests for our second annual CEO and investor dialogue on the sidelines of the Jefferies London Healthcare Conference.

Register today. Space is limited.

RATES:

- BIA members / BioCentury subscribers £195
- Industry pass £325

This event caters to biopharma C-suite executives and investors.

CRO, CMO, economic development organizations, law firms, communications/IR firms, consultants, executive recruiters, merchants, and other service providers interested in attending are encouraged to reach out to [email protected] to request additional information on sponsorship opportunities.